JB Chemicals & Pharmaceuticals Live BSE/NSE | JB Chemicals & Pharmaceuticals Fundamenta data | JB Chemicals & Pharmaceuticals Balance sheet | JB Chemicals & Pharmaceuticals Quarterly Results | JB Chemicals & Pharmaceuticals Profit & Loss | JB Chemicals & Pharmaceuticals Financial Ratios

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

7,783.85
23.63
2

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

7,784.94
1.09%
5.01

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

10 Years
5 Years
3 Years

7.14
7.58
7.87

EBITDA CAGR (%)

10 Years
5 Years
3 Years

6.98
12.88
13.65

PAT CAGR (%)

10 Years
5 Years
3 Years

6.92
11.04
25.28

P:E (Median)

8 Years
5 Years
3 Years

17.28
17.21
16.73

P:BV (Average)

8 Years
5 Years
3 Years

1.93
2.33
2.32

EV:EBITDA (Average)

8 Years
5 Years
3 Years

9.42
10.50
10.20

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Jun 20 Jun 19 Var% Mar 20 Mar 19 Var% Dec 19 Dec 18 Var% Sep 19 Sep 18 Var%
Net Sales 490 411 19% 417 379 10% 385 352 9% 428 404 6%
Expenses 331 319 4% 326 320 2% 301 280 8% 327 322 2%
EBITDA 158 92 71% 91 59 53% 84 72 16% 101 82 23%
EBIDTM 32% 22% 0% 16% 22% 21% 24% 20%
Other Income 23 12 83% 3 15 -81% 16 16 3% 18 8 123%
Interest 4 1 366% 0 1 -53% 1 1 -33% 1 1 21%
Depreciation 17 16 9% 17 11 46% 17 14 14% 16 14 12%
PBT 160 88 81% 67 62 7% 83 72 14% 102 75 36%
Tax 38 29 31% 16 20 -21% 21 26 -21% 6 24 -75%
PAT 122 59 106% 51 42 21% 62 46 34% 96 51 87%
PATM 25% 14% 3% 11% 16% 13% 22% 13%
EPS 15.77 7.65 106% 6.58 5.46 21% 8.04 6.00 34% 12.41 6.65 87%

Description Jun 20 Jun 19 Var% Mar 20 Mar 19 Var% Dec 19 Dec 18 Var% Sep 19 Sep 18 Var%
Net Sales 522 446 17% 444 419 6% 429 382 12% 456 435 5%
Expenses 367 350 5% 352 354 -1% 339 304 12% 356 354 1%
EBITDA 155 96 62% 92 65 41% 90 78 15% 100 82 23%
EBIDTM 30% 22% 14% 16% 21% 20% 22% 19%
Other Income 23 13 80% 3 16 -80% 16 16 4% 19 9 116%
Interest 4 1 369% 0 1 -36% 1 1 -35% 1 1 14%
Depreciation 17 16 9% 17 12 50% 17 15 14% 16 15 12%
PBT 157 92 71% 67 68 -2% 88 78 14% 102 75 36%
Tax 38 30 26% 17 21 -21% 22 28 -21% 8 23 -66%
PAT 120 62 92% 50 47 7% 66 50 33% 94 51 82%
PATM 23% 14% 7% 11% 16% 13% 21% 12%
EPS 15.46 8.04 92% 6.48 6.05 7% 8.60 6.46 33% 12.13 6.66 82%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Description TTM Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Net Sales 1,720 1,641 1,501 1,255 1,199 1,165 1,061 957 816 686 807 Net Sales Growth 11% 9% 20% 5% 3% 10% 11% 17% 19% -15% Cost Of Goods Sold 946 569 536 484 469 470 323 381 341 271 246 Gross Profit 774 1,072 965 771 729 695 739 576 475 415 561 GP Margin 45% 65% 64% 61% 61% 60% 70% 60% 58% 60% 69% Total Expenditure 1,285 1,272 1,213 1,073 980 939 868 802 705 622 639 Power & Fuel Cost - 62 63 58 55 55 53 47 40 30 23 % Of Sales - 4% 4% 5% 5% 5% 5% 5% 5% 4% 3% Employee Cost - 294 258 217 188 166 147 132 120 101 116 % Of Sales - 18% 17% 17% 16% 14% 14% 14% 15% 15% 14% Manufacturing Exp. - 129 140 131 123 119 223 102 62 53 61 % Of Sales - 8% 9% 10% 10% 10% 21% 11% 8% 8% 8% General & Admin Exp. - 46 50 50 39 32 30 29 26 27 24 % Of Sales - 3% 3% 4% 3% 3% 3% 3% 3% 4% 3% Selling & Distn. Exp. - 107 105 59 49 48 47 70 55 59 124 % Of Sales - 6% 7% 5% 4% 4% 4% 7% 7% 9% 15% Miscellaneous Exp. - 66 60 73 57 49 45 42 61 81 124 % Of Sales - 4% 4% 6% 5% 4% 4% 4% 7% 12% 5% EBITDA 434 368 288 182 219 226 193 154 111 64 168 EBITDA Margin 25% 22% 19% 15% 18% 19% 18% 16% 14% 9% 21% Other Income 60 50 40 56 50 56 10 38 26 29 6 Interest 6 3 5 3 5 10 7 6 5 22 10 Depreciation 66 65 55 56 46 40 38 27 24 22 23 PBT 411 350 269 179 217 231 159 158 108 49 141 Tax 80 71 87 51 44 51 46 26 23 167 23 Tax Rate 20% 21% 32% 29% 20% 22% 29% 27% 21% 21% 16% PAT 331 268 182 128 173 179 114 68 85 643 118 PAT before Minority Interest 331 268 182 128 173 179 114 68 85 643 118 Minority Interest 0 0 0 0 0 0 0 0 0 0 0 PAT Margin 19% 16% 12% 10% 14% 15% 11% 7% 10% 94% 15% PAT Growth 66% 47% 42% -26% -3% 58% 66% -19% -87% 444% EPS 42.81 34.69 23.55 16.56 22.38 23.18 14.69 8.85 10.99 83.14 15.29

Description

TTM

Mar 20

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Net Sales

1,720

1,641

1,501

1,255

1,199

1,165

1,061

957

816

686

807

Net Sales Growth

11%

20%

10%

11%

17%

19%

-15%

Cost Of Goods Sold

946

569

536

484

469

470

323

381

341

271

246

Gross Profit

774

1,072

965

771

729

695

739

576

475

415

561

GP Margin

45%

65%

64%

61%

60%

70%

60%

58%

60%

69%

Total Expenditure

1,285

1,272

1,213

1,073

980

939

868

802

705

622

639

Power & Fuel Cost

% Of Sales

Employee Cost

294

258

217

188

166

147

132

120

101

116

% Of Sales

18%

17%

16%

14%

15%

14%

Manufacturing Exp.

129

140

131

123

119

223

102

% Of Sales

10%

21%

11%

General & Admin Exp.

% Of Sales

Selling & Distn. Exp.

107

105

124

% Of Sales

15%

Miscellaneous Exp.

124

% Of Sales

12%

EBITDA

434

368

288

182

219

226

193

154

111

168

EBITDA Margin

25%

22%

19%

15%

18%

19%

18%

16%

14%

21%

Other Income

Interest

Depreciation

PBT

411

350

269

179

217

231

159

158

108

141

Tax

167

Tax Rate

20%

21%

32%

29%

20%

22%

29%

27%

21%

16%

PAT

331

268

182

128

173

179

114

643

118

PAT before Minority Interest

331

268

182

128

173

179

114

643

118

Minority Interest

PAT Margin

19%

16%

12%

10%

14%

15%

11%

10%

94%

15%

PAT Growth

66%

47%

42%

-26%

-3%

58%

66%

-19%

-87%

444%

EPS

42.81

34.69

23.55

16.56

22.38

23.18

14.69

8.85

10.99

83.14

15.29

Description TTM Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Net Sales 1,851 1,775 1,643 1,414 1,368 1,232 1,144 1,022 866 802 891 Net Sales Growth 10% 8% 16% 3% 11% 8% 12% 18% 8% -10% Cost Of Goods Sold 5,147 631 596 542 552 491 341 414 372 320 277 Gross Profit -3,297 1,144 1,047 871 816 740 803 608 495 482 614 GP Margin -178% 64% 64% 62% 60% 60% 70% 59% 57% 60% 69% Total Expenditure 1,414 1,397 1,337 1,215 1,136 1,026 964 874 760 702 698 Power & Fuel Cost - 62 63 58 55 55 53 47 40 30 23 % Of Sales - 3% 4% 4% 4% 4% 5% 5% 5% 4% 3% Employee Cost - 323 288 251 217 175 160 144 130 113 125 % Of Sales - 18% 18% 18% 16% 14% 14% 14% 15% 14% 14% Manufacturing Exp. - 141 150 140 131 119 224 102 62 53 61 % Of Sales - 8% 9% 10% 10% 10% 20% 10% 7% 7% 7% General & Admin Exp. - 49 53 54 42 35 32 32 28 31 38 % Of Sales - 3% 3% 4% 3% 3% 3% 3% 3% 4% 4% Selling & Distn. Exp. - 117 114 87 78 73 75 74 56 69 132 % Of Sales - 7% 7% 6% 6% 6% 7% 7% 6% 9% 15% Miscellaneous Exp. - 75 72 82 60 77 79 62 73 86 132 % Of Sales - 4% 4% 6% 4% 6% 7% 6% 8% 11% 5% EBITDA 437 378 306 199 232 206 180 148 106 100 192 EBITDA Margin 24% 21% 19% 14% 17% 17% 16% 14% 12% 13% 22% Other Income 61 51 41 55 50 57 11 38 28 29 6 Interest 6 3 5 3 5 11 7 6 5 24 10 Depreciation 68 66 56 57 47 41 39 28 25 22 23 PBT 414 359 287 194 230 211 146 152 104 83 165 Tax 84 76 93 55 46 50 45 26 24 166 26 Tax Rate 20% 22% 32% 28% 20% 24% 31% 30% 23% 20% 16% PAT 330 272 193 138 184 161 100 62 79 678 139 PAT before Minority Interest 329 272 194 139 184 161 100 62 79 678 139 Minority Interest 0 0 0 0 0 0 0 0 0 0 0 PAT Margin 18% 15% 12% 10% 13% 13% 9% 6% 9% 85% 16% PAT Growth 57% 41% 40% -25% 14% 60% 63% -23% -88% 387% EPS 42.66 35.19 25.03 17.90 23.81 20.85 12.99 7.96 10.28 87.70 18.02

Description

TTM

Mar 20

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Net Sales

1,851

1,775

1,643

1,414

1,368

1,232

1,144

1,022

866

802

891

Net Sales Growth

10%

16%

11%

12%

18%

-10%

Cost Of Goods Sold

5,147

631

596

542

552

491

341

414

372

320

277

Gross Profit

-3,297

1,144

1,047

871

816

740

803

608

495

482

614

GP Margin

-178%

64%

62%

60%

70%

59%

57%

60%

69%

Total Expenditure

1,414

1,397

1,337

1,215

1,136

1,026

964

874

760

702

698

Power & Fuel Cost

% Of Sales

Employee Cost

323

288

251

217

175

160

144

130

113

125

% Of Sales

18%

16%

14%

15%

14%

Manufacturing Exp.

141

150

140

131

119

224

102

% Of Sales

10%

20%

10%

General & Admin Exp.

% Of Sales

Selling & Distn. Exp.

117

114

132

% Of Sales

15%

Miscellaneous Exp.

132

% Of Sales

11%

EBITDA

437

378

306

199

232

206

180

148

106

100

192

EBITDA Margin

24%

21%

19%

14%

17%

16%

14%

12%

13%

22%

Other Income

Interest

Depreciation

PBT

414

359

287

194

230

211

146

152

104

165

Tax

166

Tax Rate

20%

22%

32%

28%

20%

24%

31%

30%

23%

20%

16%

PAT

330

272

193

138

184

161

100

678

139

PAT before Minority Interest

329

272

194

139

184

161

100

678

139

Minority Interest

PAT Margin

18%

15%

12%

10%

13%

85%

16%

PAT Growth

57%

41%

40%

-25%

14%

60%

63%

-23%

-88%

387%

EPS

42.66

35.19

25.03

17.90

23.81

20.85

12.99

7.96

10.28

87.70

18.02

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Shareholder's Funds 1,445 1,485 1,453 1,388 1,223 1,016 1,048 1,009 954 713 Share Capital 15 16 17 17 17 17 17 17 17 17 Total Reserves 1,430 1,469 1,437 1,371 1,206 999 1,031 992 937 696 Non-Current Liabilities 73 79 63 42 46 34 33 37 36 33 Secured Loans 0 0 0 0 0 0 0 0 0 1 Unsecured Loans 0 0 0 0 0 0 0 7 11 11 Long Term Provisions 7 6 10 9 10 12 12 8 8 7 Current Liabilities 493 763 712 667 736 398 262 226 183 261 Trade Payables 111 111 100 79 69 62 52 52 34 44 Other Current Liabilities 138 87 113 118 119 83 94 98 77 56 Short Term Borrowings 32 26 28 49 174 105 81 37 55 133 Short Term Provisions 211 539 470 421 374 149 35 39 17 27 Total Liabilities 2,012 2,327 2,228 2,097 2,005 1,449 1,342 1,273 1,173 1,007 Net Block 583 552 570 609 369 301 282 294 241 225 Gross Block 1,105 1,012 980 964 680 572 511 497 421 387 Accumulated Depreciation 522 460 410 355 310 271 229 203 180 162 Non Current Assets 806 805 781 941 892 604 378 352 331 283 Capital Work in Progress 16 15 17 4 135 55 46 5 39 4 Non Current Investment 202 229 183 319 364 231 39 39 39 42 Long Term Loans & Adv. 4 8 10 9 23 18 11 14 13 12 Other Non Current Assets 0 1 1 1 0 0 0 0 0 0 Current Assets 1,206 1,522 1,447 1,155 1,113 844 964 920 841 724 Current Investments 334 361 384 225 247 367 497 395 299 81 Inventories 232 208 176 160 133 128 111 90 91 82 Sundry Debtors 344 300 301 265 266 248 248 195 131 385 Cash & Bank 12 21 15 7 11 9 11 149 211 123 Other Current Assets 284 32 11 12 456 92 97 92 109 53 Short Term Loans & Adv. 267 600 561 486 454 91 96 92 109 52 Net Current Assets 713 759 735 488 377 446 702 694 659 463 Total Assets 2,012 2,327 2,228 2,097 2,005 1,449 1,342 1,273 1,173 1,007

Description

Mar 20

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Shareholder's Funds

1,445

1,485

1,453

1,388

1,223

1,016

1,048

1,009

954

713

Share Capital

Total Reserves

1,430

1,469

1,437

1,371

1,206

999

1,031

992

937

696

Non-Current Liabilities

Secured Loans

Unsecured Loans

Long Term Provisions

Current Liabilities

493

763

712

667

736

398

262

226

183

261

Trade Payables

111

100

Other Current Liabilities

138

113

118

119

Short Term Borrowings

174

105

133

Short Term Provisions

211

539

470

421

374

149

Total Liabilities

2,012

2,327

2,228

2,097

2,005

1,449

1,342

1,273

1,173

1,007

Net Block

583

552

570

609

369

301

282

294

241

225

Gross Block

1,105

1,012

980

964

680

572

511

497

421

387

Accumulated Depreciation

522

460

410

355

310

271

229

203

180

162

Non Current Assets

806

805

781

941

892

604

378

352

331

283

Capital Work in Progress

135

Non Current Investment

202

229

183

319

364

231

Long Term Loans & Adv.

Other Non Current Assets

Current Assets

1,206

1,522

1,447

1,155

1,113

844

964

920

841

724

Current Investments

334

361

384

225

247

367

497

395

299

Inventories

232

208

176

160

133

128

111

Sundry Debtors

344

300

301

265

266

248

195

131

385

Cash & Bank

149

211

123

Other Current Assets

284

456

109

Short Term Loans & Adv.

267

600

561

486

454

109

Net Current Assets

713

759

735

488

377

446

702

694

659

463

Total Assets

2,012

2,327

2,228

2,097

2,005

1,449

1,342

1,273

1,173

1,007

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Shareholder's Funds 1,435 1,480 1,442 1,364 1,184 995 1,043 1,020 970 692 Share Capital 15 16 17 17 17 17 17 17 17 17 Total Reserves 1,420 1,464 1,425 1,347 1,167 978 1,026 1,003 953 674 Non-Current Liabilities 63 65 46 27 31 33 32 40 40 36 Secured Loans 0 0 0 0 0 0 0 0 0 1 Unsecured Loans 0 0 0 0 0 0 0 7 12 12 Long Term Provisions 7 6 10 13 10 12 12 8 8 8 Current Liabilities 516 782 736 693 797 460 276 239 188 271 Trade Payables 124 117 110 99 91 78 61 61 37 50 Other Current Liabilities 144 93 120 122 139 104 98 101 79 61 Short Term Borrowings 32 26 29 49 193 127 82 37 55 133 Short Term Provisions 216 545 477 423 375 152 36 41 17 27 Total Liabilities 2,016 2,329 2,226 2,086 2,014 1,487 1,351 1,300 1,198 999 Net Block 651 621 640 679 440 329 311 334 276 258 Gross Block 1,177 1,085 1,054 1,039 754 602 541 537 457 420 Accumulated Depreciation 526 464 414 359 314 273 230 203 180 162 Non Current Assets 741 741 718 879 832 586 370 356 332 279 Capital Work in Progress 16 15 17 4 135 55 46 5 39 4 Non Current Investment 69 96 50 186 231 185 3 3 3 4 Long Term Loans & Adv. 4 8 10 9 23 18 11 14 13 13 Other Non Current Assets 0 1 1 1 2 0 0 0 0 0 Current Assets 1,276 1,589 1,509 1,207 1,182 901 981 944 866 721 Current Investments 334 361 384 225 247 367 497 395 299 81 Inventories 275 244 214 200 188 150 134 105 101 112 Sundry Debtors 345 308 301 266 273 262 236 191 136 346 Cash & Bank 31 37 30 13 13 25 12 156 220 127 Other Current Assets 291 33 13 14 461 96 102 97 111 55 Short Term Loans & Adv. 272 606 568 488 459 96 101 97 110 55 Net Current Assets 760 807 772 514 385 441 704 704 678 449 Total Assets 2,016 2,329 2,226 2,086 2,014 1,487 1,351 1,300 1,198 999

Description

Mar 20

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Shareholder's Funds

1,435

1,480

1,442

1,364

1,184

995

1,043

1,020

970

692

Share Capital

Total Reserves

1,420

1,464

1,425

1,347

1,167

978

1,026

1,003

953

674

Non-Current Liabilities

Secured Loans

Unsecured Loans

Long Term Provisions

Current Liabilities

516

782

736

693

797

460

276

239

188

271

Trade Payables

124

117

110

Other Current Liabilities

144

120

122

139

104

101

Short Term Borrowings

193

127

133

Short Term Provisions

216

545

477

423

375

152

Total Liabilities

2,016

2,329

2,226

2,086

2,014

1,487

1,351

1,300

1,198

999

Net Block

651

621

640

679

440

329

311

334

276

258

Gross Block

1,177

1,085

1,054

1,039

754

602

541

537

457

420

Accumulated Depreciation

526

464

414

359

314

273

230

203

180

162

Non Current Assets

741

718

879

832

586

370

356

332

279

Capital Work in Progress

135

Non Current Investment

186

231

185

Long Term Loans & Adv.

Other Non Current Assets

Current Assets

1,276

1,589

1,509

1,207

1,182

901

981

944

866

721

Current Investments

334

361

384

225

247

367

497

395

299

Inventories

275

244

214

200

188

150

134

105

101

112

Sundry Debtors

345

308

301

266

273

262

236

191

136

346

Cash & Bank

156

220

127

Other Current Assets

291

461

102

111

Short Term Loans & Adv.

272

606

568

488

459

101

110

Net Current Assets

760

807

772

514

385

441

704

678

449

Total Assets

2,016

2,329

2,226

2,086

2,014

1,487

1,351

1,300

1,198

999

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Cash From Operating Activity 272 193 116 178 171 143 -12 80 851 137 PBT 340 269 179 217 231 159 94 108 809 141 Adjustment 15 27 15 10 -10 36 14 -6 4 24 Changes in Working Capital 4 -42 -40 0 1 -14 -93 1 203 2 Cash after chg. in Working capital 359 254 154 226 222 181 15 102 1,015 166 Interest Paid 0 0 0 0 0 0 0 0 0 0 Tax Paid -87 -61 -38 -49 -51 -38 -27 -22 -165 -30 Other Direct Exp. Paid 0 0 0 0 0 0 0 0 0 0 Extra & Other Items 0 0 0 0 0 0 0 0 0 0 Cash From Investing Activity 24 -28 -24 -42 -52 -122 -139 -112 -236 -89 Net Fixed Assets -94 -30 -30 -153 -188 -70 -55 -42 -70 -33 Net Investments 53 -23 -23 68 -14 -61 -102 -96 -214 -61 Others 65 25 29 43 150 9 19 26 48 4 Cash from Financing Activity -305 -156 -59 -165 -97 -23 12 -31 -526 5 Net Cash Inflow / Outflow -10 9 32 -30 22 -2 -138 -62 88 52 Opening Cash & Equivalents 16 7 -25 4 -14 11 149 211 123 71 Closing Cash & Equivalent 6 16 7 -25 7 9 11 149 211 123

Description

Mar 20

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Cash From Operating Activity

272

193

116

178

171

143

-12

851

137

PBT

340

269

179

217

231

159

108

809

141

Adjustment

-10

-6

Changes in Working Capital

-42

-40

-14

-93

203

Cash after chg. in Working capital

359

254

154

226

222

181

102

1,015

166

Interest Paid

Tax Paid

-87

-61

-38

-49

-51

-38

-27

-22

-165

-30

Other Direct Exp. Paid

Extra & Other Items

Cash From Investing Activity

-28

-24

-42

-52

-122

-139

-112

-236

-89

Net Fixed Assets

-94

-30

-153

-188

-70

-55

-42

-70

-33

Net Investments

-23

-14

-61

-102

-96

-214

-61

Others

150

Cash from Financing Activity

-305

-156

-59

-165

-97

-23

-31

-526

Net Cash Inflow / Outflow

-10

-30

-2

-138

-62

Opening Cash & Equivalents

-25

-14

149

211

123

Closing Cash & Equivalent

-25

149

211

123

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Cash From Operating Activity 275 194 123 201 140 127 -14 84 880 134 PBT 349 287 194 230 212 146 87 104 843 165 Adjustment 8 24 17 13 -1 39 21 -4 33 17 Changes in Working Capital 9 -51 -47 6 -17 -20 -94 9 167 -16 Cash after chg. in Working capital 366 259 164 249 194 165 14 109 1,044 166 Interest Paid 0 0 0 0 0 0 0 0 0 0 Tax Paid -91 -65 -41 -48 -53 -38 -28 -24 -164 -32 Other Direct Exp. Paid 0 0 0 0 0 0 0 0 0 0 Extra & Other Items 0 0 0 0 0 0 0 0 0 0 Cash From Investing Activity 24 -28 -21 -45 -28 -112 -142 -116 -261 -89 Net Fixed Assets -94 -30 -30 -153 -188 -70 -55 -42 -70 -33 Net Investments 53 -23 -23 68 -14 -61 -102 -96 -214 -61 Others 65 25 32 40 174 19 15 22 23 4 Cash from Financing Activity -306 -156 -60 -184 -100 -1 12 -31 -526 5 Net Cash Inflow / Outflow -6 11 43 -28 13 13 -144 -63 93 49 Opening Cash & Equivalents 32 21 -21 7 -5 12 156 220 127 78 Closing Cash & Equivalent 26 32 21 -21 9 25 12 156 220 127

Description

Mar 20

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Cash From Operating Activity

275

194

123

201

140

127

-14

880

134

PBT

349

287

194

230

212

146

104

843

165

Adjustment

-1

-4

Changes in Working Capital

-51

-47

-17

-20

-94

167

-16

Cash after chg. in Working capital

366

259

164

249

194

165

109

1,044

166

Interest Paid

Tax Paid

-91

-65

-41

-48

-53

-38

-28

-24

-164

-32

Other Direct Exp. Paid

Extra & Other Items

Cash From Investing Activity

-28

-21

-45

-28

-112

-142

-116

-261

-89

Net Fixed Assets

-94

-30

-153

-188

-70

-55

-42

-70

-33

Net Investments

-23

-14

-61

-102

-96

-214

-61

Others

174

Cash from Financing Activity

-306

-156

-60

-184

-100

-1

-31

-526

Net Cash Inflow / Outflow

-6

-28

-144

-63

Opening Cash & Equivalents

-21

-5

156

220

127

Closing Cash & Equivalent

-21

156

220

127

Financial Ratios

Consolidated /

Standalone

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Book Value (Rs.) 187 185 174 164 144 120 124 119 113 84 ROA 12% 8% 6% 8% 10% 8% 5% 7% 59% 13% ROE 18% 12% 9% 13% 16% 11% 7% 9% 77% 18% ROCE 23% 18% 12% 16% 19% 15% 9% 11% 87% 19% Fixed Asset Turnover 1.55 1.51 1.29 1.46 1.86 1.99 1.92 1.80 1.72 2.18 Receivable days 72 73 82 81 81 84 83 72 136 178 Inventory Days 49 47 49 45 41 41 38 40 45 31 Payable days 33 33 33 29 27 25 25 24 26 27 Cash Conversion Cycle 87 87 98 96 95 100 97 87 155 182 Total Debt/Equity 0.02 0.02 0.02 0.04 0.14 0.10 0.09 0.05 0.07 0.24 Interest Cover 108 60 53 44 23 25 17 22 38 15

Description

Mar 20

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Book Value (Rs.)

187

185

174

164

144

120

124

119

113

ROA

12%

10%

59%

13%

ROE

18%

12%

13%

16%

11%

77%

18%

ROCE

23%

18%

12%

16%

19%

15%

11%

87%

19%

Fixed Asset Turnover

1.55

1.51

1.29

1.46

1.86

1.99

1.92

1.80

1.72

2.18

Receivable days

136

178

Inventory Days

Payable days

Cash Conversion Cycle

100

155

182

Total Debt/Equity

0.02

0.04

0.14

0.10

0.09

0.05

0.07

0.24

Interest Cover

108

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Book Value (Rs.) 186 184 172 161 140 117 123 119 113 81 ROA 13% 9% 6% 9% 9% 7% 5% 6% 62% 15% ROE 19% 13% 10% 14% 15% 10% 6% 8% 82% 22% ROCE 24% 20% 14% 17% 18% 13% 8% 10% 92% 23% Fixed Asset Turnover 1.57 1.54 1.35 1.53 1.82 2.03 1.92 1.76 1.85 2.22 Receivable days 67 68 73 72 79 78 75 68 109 140 Inventory Days 53 51 53 52 50 45 42 43 48 40 Payable days 33 32 34 33 32 28 27 26 27 26 Cash Conversion Cycle 88 86 93 91 97 95 91 85 130 154 Total Debt/Equity 0.02 0.02 0.02 0.04 0.16 0.13 0.09 0.05 0.07 0.25 Interest Cover 108 63 57 44 21 22 16 21 36 17

Description

Mar 20

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Book Value (Rs.)

186

184

172

161

140

117

123

119

113

ROA

13%

62%

15%

ROE

19%

13%

10%

14%

15%

10%

82%

22%

ROCE

24%

20%

14%

17%

18%

13%

10%

92%

23%

Fixed Asset Turnover

1.57

1.54

1.35

1.53

1.82

2.03

1.92

1.76

1.85

2.22

Receivable days

109

140

Inventory Days

Payable days

Cash Conversion Cycle

130

154

Total Debt/Equity

0.02

0.04

0.16

0.13

0.09

0.05

0.07

0.25

Interest Cover

108

JB Chemicals & Pharmaceuticals Ltd.

Pharmaceuticals & Drugs - Domestic

BSE: 506943 | NSE: JBCHEPHARM

Stock Summary

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Consolidated Figures in Rs. Crores /

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Cash Flow

Consolidated Figures in Rs. Crores /

Financial Ratios

Consolidated /

Annual Reports:

News Update

JB Chemicals & Pharmaceuticals Ltd.

Pharmaceuticals & Drugs - Domestic

BSE: 506943 | NSE: JBCHEPHARM

Stock Summary

Shareholding Pattern

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Consolidated Figures in Rs. Crores /

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Cash Flow

Consolidated Figures in Rs. Crores /

Financial Ratios

Consolidated /

Annual Reports:

News Update